Orlistat does not have lipid-lowering effect, Orlistat is a weight loss drug for obese people and overweight people.
The drug can inhibit the body’s absorption of fatty acids, and inhibit cholesterol absorption, for mild and moderate hyperlipidemic obese patients, taking the drug has a certain effect on weight loss. Common adverse reactions are urgency of stool, oily spotting, fatty (oily) stools, increased gastrointestinal emissions, increased frequency of stools, steatorrhea, and fecal incontinence, which can be improved after a period of time of drug use in most of the population.
However, it should be noted that pregnant women, patients with chronic malabsorption syndrome, cholestasis and patients with organic obesity should avoid taking this drug.
The drug is only through the inhibition of gastric lipase activity in the stomach and small intestine, promote fat excretion, so as to achieve the purpose of fat reduction. Dyslipidemia belongs to metabolic diseases, is the human body lipid metabolism is abnormal, orlistat does not have the effect of regulating fat, so generally not used in the treatment of hyperlipidemia.
Warm tips: people with dyslipidemia should use medication under the guidance of a physician, not blindly take medication on their own.